Global HIV Drugs Market Insights, Forecast to 2029

Global HIV Drugs Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 HIV Drugs Product Introduction
1.2 Market by Type
1.2.1 Global HIV Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Multi-Class Combination Products
1.2.3 Nucleoside Reverse Transcriptase Inhibitors
1.2.4 Non-Nucleoside Reverse Transcriptase Inhibitors
1.2.5 Protease Inhibitors
1.2.6 Fusion Inhibitors
1.2.7 Entry Inhibitors - CCR5 Co-Receptor Antagonist
1.2.8 HIV Integrase Strand Transfer Inhibitors
1.3 Market by Application
1.3.1 Global HIV Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global HIV Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global HIV Drugs Revenue by Region
2.2.1 Global HIV Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global HIV Drugs Revenue by Region (2018-2023)
2.2.3 Global HIV Drugs Revenue by Region (2024-2029)
2.2.4 Global HIV Drugs Revenue Market Share by Region (2018-2029)
2.3 Global HIV Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global HIV Drugs Sales by Region
2.4.1 Global HIV Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global HIV Drugs Sales by Region (2018-2023)
2.4.3 Global HIV Drugs Sales by Region (2024-2029)
2.4.4 Global HIV Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global HIV Drugs Sales by Manufacturers
3.1.1 Global HIV Drugs Sales by Manufacturers (2018-2023)
3.1.2 Global HIV Drugs Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of HIV Drugs in 2022
3.2 Global HIV Drugs Revenue by Manufacturers
3.2.1 Global HIV Drugs Revenue by Manufacturers (2018-2023)
3.2.2 Global HIV Drugs Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by HIV Drugs Revenue in 2022
3.3 Global Key Players of HIV Drugs, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global HIV Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global HIV Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of HIV Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of HIV Drugs, Product Offered and Application
3.8 Global Key Manufacturers of HIV Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global HIV Drugs Sales by Type
4.1.1 Global HIV Drugs Historical Sales by Type (2018-2023)
4.1.2 Global HIV Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global HIV Drugs Sales Market Share by Type (2018-2029)
4.2 Global HIV Drugs Revenue by Type
4.2.1 Global HIV Drugs Historical Revenue by Type (2018-2023)
4.2.2 Global HIV Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global HIV Drugs Revenue Market Share by Type (2018-2029)
4.3 Global HIV Drugs Price by Type
4.3.1 Global HIV Drugs Price by Type (2018-2023)
4.3.2 Global HIV Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global HIV Drugs Sales by Application
5.1.1 Global HIV Drugs Historical Sales by Application (2018-2023)
5.1.2 Global HIV Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global HIV Drugs Sales Market Share by Application (2018-2029)
5.2 Global HIV Drugs Revenue by Application
5.2.1 Global HIV Drugs Historical Revenue by Application (2018-2023)
5.2.2 Global HIV Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global HIV Drugs Revenue Market Share by Application (2018-2029)
5.3 Global HIV Drugs Price by Application
5.3.1 Global HIV Drugs Price by Application (2018-2023)
5.3.2 Global HIV Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada HIV Drugs Market Size by Type
6.1.1 US & Canada HIV Drugs Sales by Type (2018-2029)
6.1.2 US & Canada HIV Drugs Revenue by Type (2018-2029)
6.2 US & Canada HIV Drugs Market Size by Application
6.2.1 US & Canada HIV Drugs Sales by Application (2018-2029)
6.2.2 US & Canada HIV Drugs Revenue by Application (2018-2029)
6.3 US & Canada HIV Drugs Market Size by Country
6.3.1 US & Canada HIV Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada HIV Drugs Sales by Country (2018-2029)
6.3.3 US & Canada HIV Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe HIV Drugs Market Size by Type
7.1.1 Europe HIV Drugs Sales by Type (2018-2029)
7.1.2 Europe HIV Drugs Revenue by Type (2018-2029)
7.2 Europe HIV Drugs Market Size by Application
7.2.1 Europe HIV Drugs Sales by Application (2018-2029)
7.2.2 Europe HIV Drugs Revenue by Application (2018-2029)
7.3 Europe HIV Drugs Market Size by Country
7.3.1 Europe HIV Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe HIV Drugs Sales by Country (2018-2029)
7.3.3 Europe HIV Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China HIV Drugs Market Size
8.1.1 China HIV Drugs Sales (2018-2029)
8.1.2 China HIV Drugs Revenue (2018-2029)
8.2 China HIV Drugs Market Size by Application
8.2.1 China HIV Drugs Sales by Application (2018-2029)
8.2.2 China HIV Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia HIV Drugs Market Size by Type
9.1.1 Asia HIV Drugs Sales by Type (2018-2029)
9.1.2 Asia HIV Drugs Revenue by Type (2018-2029)
9.2 Asia HIV Drugs Market Size by Application
9.2.1 Asia HIV Drugs Sales by Application (2018-2029)
9.2.2 Asia HIV Drugs Revenue by Application (2018-2029)
9.3 Asia HIV Drugs Sales by Region
9.3.1 Asia HIV Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia HIV Drugs Revenue by Region (2018-2029)
9.3.3 Asia HIV Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America HIV Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America HIV Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America HIV Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America HIV Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America HIV Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America HIV Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America HIV Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America HIV Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America HIV Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America HIV Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Information
11.1.2 Bristol-Myers Squibb Overview
11.1.3 Bristol-Myers Squibb HIV Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Bristol-Myers Squibb HIV Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bristol-Myers Squibb Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences Overview
11.2.3 Gilead Sciences HIV Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Gilead Sciences HIV Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Gilead Sciences Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Overview
11.3.3 GlaxoSmithKline HIV Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 GlaxoSmithKline HIV Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson HIV Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Johnson & Johnson HIV Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson & Johnson Recent Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Overview
11.5.3 Merck HIV Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Merck HIV Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 HIV Drugs Industry Chain Analysis
12.2 HIV Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 HIV Drugs Production Mode & Process
12.4 HIV Drugs Sales and Marketing
12.4.1 HIV Drugs Sales Channels
12.4.2 HIV Drugs Distributors
12.5 HIV Drugs Customers
13 Market Dynamics
13.1 HIV Drugs Industry Trends
13.2 HIV Drugs Market Drivers
13.3 HIV Drugs Market Challenges
13.4 HIV Drugs Market Restraints
14 Key Findings in The Global HIV Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global HIV Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Multi-Class Combination Products
Table 3. Major Manufacturers of Nucleoside Reverse Transcriptase Inhibitors
Table 4. Major Manufacturers of Non-Nucleoside Reverse Transcriptase Inhibitors
Table 5. Major Manufacturers of Protease Inhibitors
Table 6. Major Manufacturers of Fusion Inhibitors
Table 7. Major Manufacturers of Entry Inhibitors - CCR5 Co-Receptor Antagonist
Table 8. Major Manufacturers of HIV Integrase Strand Transfer Inhibitors
Table 9. Global HIV Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global HIV Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global HIV Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 12. Global HIV Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 13. Global HIV Drugs Revenue Market Share by Region (2018-2023)
Table 14. Global HIV Drugs Revenue Market Share by Region (2024-2029)
Table 15. Global HIV Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 16. Global HIV Drugs Sales by Region (2018-2023) & (K Units)
Table 17. Global HIV Drugs Sales by Region (2024-2029) & (K Units)
Table 18. Global HIV Drugs Sales Market Share by Region (2018-2023)
Table 19. Global HIV Drugs Sales Market Share by Region (2024-2029)
Table 20. Global HIV Drugs Sales by Manufacturers (2018-2023) & (K Units)
Table 21. Global HIV Drugs Sales Share by Manufacturers (2018-2023)
Table 22. Global HIV Drugs Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 23. Global HIV Drugs Revenue Share by Manufacturers (2018-2023)
Table 24. Global Key Players of HIV Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 25. HIV Drugs Price by Manufacturers 2018-2023 (USD/Unit)
Table 26. Global HIV Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global HIV Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Drugs as of 2022)
Table 28. Global Key Manufacturers of HIV Drugs, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of HIV Drugs, Product Offered and Application
Table 30. Global Key Manufacturers of HIV Drugs, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global HIV Drugs Sales by Type (2018-2023) & (K Units)
Table 33. Global HIV Drugs Sales by Type (2024-2029) & (K Units)
Table 34. Global HIV Drugs Sales Share by Type (2018-2023)
Table 35. Global HIV Drugs Sales Share by Type (2024-2029)
Table 36. Global HIV Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 37. Global HIV Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 38. Global HIV Drugs Revenue Share by Type (2018-2023)
Table 39. Global HIV Drugs Revenue Share by Type (2024-2029)
Table 40. HIV Drugs Price by Type (2018-2023) & (USD/Unit)
Table 41. Global HIV Drugs Price Forecast by Type (2024-2029) & (USD/Unit)
Table 42. Global HIV Drugs Sales by Application (2018-2023) & (K Units)
Table 43. Global HIV Drugs Sales by Application (2024-2029) & (K Units)
Table 44. Global HIV Drugs Sales Share by Application (2018-2023)
Table 45. Global HIV Drugs Sales Share by Application (2024-2029)
Table 46. Global HIV Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global HIV Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 48. Global HIV Drugs Revenue Share by Application (2018-2023)
Table 49. Global HIV Drugs Revenue Share by Application (2024-2029)
Table 50. HIV Drugs Price by Application (2018-2023) & (USD/Unit)
Table 51. Global HIV Drugs Price Forecast by Application (2024-2029) & (USD/Unit)
Table 52. US & Canada HIV Drugs Sales by Type (2018-2023) & (K Units)
Table 53. US & Canada HIV Drugs Sales by Type (2024-2029) & (K Units)
Table 54. US & Canada HIV Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 55. US & Canada HIV Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 56. US & Canada HIV Drugs Sales by Application (2018-2023) & (K Units)
Table 57. US & Canada HIV Drugs Sales by Application (2024-2029) & (K Units)
Table 58. US & Canada HIV Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 59. US & Canada HIV Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 60. US & Canada HIV Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 61. US & Canada HIV Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 62. US & Canada HIV Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 63. US & Canada HIV Drugs Sales by Country (2018-2023) & (K Units)
Table 64. US & Canada HIV Drugs Sales by Country (2024-2029) & (K Units)
Table 65. Europe HIV Drugs Sales by Type (2018-2023) & (K Units)
Table 66. Europe HIV Drugs Sales by Type (2024-2029) & (K Units)
Table 67. Europe HIV Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe HIV Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 69. Europe HIV Drugs Sales by Application (2018-2023) & (K Units)
Table 70. Europe HIV Drugs Sales by Application (2024-2029) & (K Units)
Table 71. Europe HIV Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe HIV Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 73. Europe HIV Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 74. Europe HIV Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe HIV Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 76. Europe HIV Drugs Sales by Country (2018-2023) & (K Units)
Table 77. Europe HIV Drugs Sales by Country (2024-2029) & (K Units)
Table 78. China HIV Drugs Sales by Type (2018-2023) & (K Units)
Table 79. China HIV Drugs Sales by Type (2024-2029) & (K Units)
Table 80. China HIV Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 81. China HIV Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 82. China HIV Drugs Sales by Application (2018-2023) & (K Units)
Table 83. China HIV Drugs Sales by Application (2024-2029) & (K Units)
Table 84. China HIV Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 85. China HIV Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 86. Asia HIV Drugs Sales by Type (2018-2023) & (K Units)
Table 87. Asia HIV Drugs Sales by Type (2024-2029) & (K Units)
Table 88. Asia HIV Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 89. Asia HIV Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 90. Asia HIV Drugs Sales by Application (2018-2023) & (K Units)
Table 91. Asia HIV Drugs Sales by Application (2024-2029) & (K Units)
Table 92. Asia HIV Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 93. Asia HIV Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 94. Asia HIV Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 95. Asia HIV Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 96. Asia HIV Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 97. Asia HIV Drugs Sales by Region (2018-2023) & (K Units)
Table 98. Asia HIV Drugs Sales by Region (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America HIV Drugs Sales by Type (2018-2023) & (K Units)
Table 100. Middle East, Africa and Latin America HIV Drugs Sales by Type (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America HIV Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America HIV Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America HIV Drugs Sales by Application (2018-2023) & (K Units)
Table 104. Middle East, Africa and Latin America HIV Drugs Sales by Application (2024-2029) & (K Units)
Table 105. Middle East, Africa and Latin America HIV Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America HIV Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America HIV Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 108. Middle East, Africa and Latin America HIV Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America HIV Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 110. Middle East, Africa and Latin America HIV Drugs Sales by Country (2018-2023) & (K Units)
Table 111. Middle East, Africa and Latin America HIV Drugs Sales by Country (2024-2029) & (K Units)
Table 112. Bristol-Myers Squibb Company Information
Table 113. Bristol-Myers Squibb Description and Major Businesses
Table 114. Bristol-Myers Squibb HIV Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 115. Bristol-Myers Squibb HIV Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Bristol-Myers Squibb Recent Developments
Table 117. Gilead Sciences Company Information
Table 118. Gilead Sciences Description and Major Businesses
Table 119. Gilead Sciences HIV Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 120. Gilead Sciences HIV Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Gilead Sciences Recent Developments
Table 122. GlaxoSmithKline Company Information
Table 123. GlaxoSmithKline Description and Major Businesses
Table 124. GlaxoSmithKline HIV Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 125. GlaxoSmithKline HIV Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. GlaxoSmithKline Recent Developments
Table 127. Johnson & Johnson Company Information
Table 128. Johnson & Johnson Description and Major Businesses
Table 129. Johnson & Johnson HIV Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 130. Johnson & Johnson HIV Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Johnson & Johnson Recent Developments
Table 132. Merck Company Information
Table 133. Merck Description and Major Businesses
Table 134. Merck HIV Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 135. Merck HIV Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Merck Recent Developments
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. HIV Drugs Distributors List
Table 140. HIV Drugs Customers List
Table 141. HIV Drugs Market Trends
Table 142. HIV Drugs Market Drivers
Table 143. HIV Drugs Market Challenges
Table 144. HIV Drugs Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. HIV Drugs Product Picture
Figure 2. Global HIV Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global HIV Drugs Market Share by Type in 2022 & 2029
Figure 4. Multi-Class Combination Products Product Picture
Figure 5. Nucleoside Reverse Transcriptase Inhibitors Product Picture
Figure 6. Non-Nucleoside Reverse Transcriptase Inhibitors Product Picture
Figure 7. Protease Inhibitors Product Picture
Figure 8. Fusion Inhibitors Product Picture
Figure 9. Entry Inhibitors - CCR5 Co-Receptor Antagonist Product Picture
Figure 10. HIV Integrase Strand Transfer Inhibitors Product Picture
Figure 11. Global HIV Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 12. Global HIV Drugs Market Share by Application in 2022 & 2029
Figure 13. Hospital Pharmacies
Figure 14. Retail Pharmacies
Figure 15. Online Pharmacies
Figure 16. Others
Figure 17. HIV Drugs Report Years Considered
Figure 18. Global HIV Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global HIV Drugs Revenue 2018-2029 (US$ Million)
Figure 20. Global HIV Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 21. Global HIV Drugs Revenue Market Share by Region (2018-2029)
Figure 22. Global HIV Drugs Sales 2018-2029 ((K Units)
Figure 23. Global HIV Drugs Sales Market Share by Region (2018-2029)
Figure 24. US & Canada HIV Drugs Sales YoY (2018-2029) & (K Units)
Figure 25. US & Canada HIV Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Europe HIV Drugs Sales YoY (2018-2029) & (K Units)
Figure 27. Europe HIV Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 28. China HIV Drugs Sales YoY (2018-2029) & (K Units)
Figure 29. China HIV Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Asia (excluding China) HIV Drugs Sales YoY (2018-2029) & (K Units)
Figure 31. Asia (excluding China) HIV Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 32. Middle East, Africa and Latin America HIV Drugs Sales YoY (2018-2029) & (K Units)
Figure 33. Middle East, Africa and Latin America HIV Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 34. The HIV Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 35. The Top 5 and 10 Largest Manufacturers of HIV Drugs in the World: Market Share by HIV Drugs Revenue in 2022
Figure 36. Global HIV Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 37. Global HIV Drugs Sales Market Share by Type (2018-2029)
Figure 38. Global HIV Drugs Revenue Market Share by Type (2018-2029)
Figure 39. Global HIV Drugs Sales Market Share by Application (2018-2029)
Figure 40. Global HIV Drugs Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada HIV Drugs Sales Market Share by Type (2018-2029)
Figure 42. US & Canada HIV Drugs Revenue Market Share by Type (2018-2029)
Figure 43. US & Canada HIV Drugs Sales Market Share by Application (2018-2029)
Figure 44. US & Canada HIV Drugs Revenue Market Share by Application (2018-2029)
Figure 45. US & Canada HIV Drugs Revenue Share by Country (2018-2029)
Figure 46. US & Canada HIV Drugs Sales Share by Country (2018-2029)
Figure 47. U.S. HIV Drugs Revenue (2018-2029) & (US$ Million)
Figure 48. Canada HIV Drugs Revenue (2018-2029) & (US$ Million)
Figure 49. Europe HIV Drugs Sales Market Share by Type (2018-2029)
Figure 50. Europe HIV Drugs Revenue Market Share by Type (2018-2029)
Figure 51. Europe HIV Drugs Sales Market Share by Application (2018-2029)
Figure 52. Europe HIV Drugs Revenue Market Share by Application (2018-2029)
Figure 53. Europe HIV Drugs Revenue Share by Country (2018-2029)
Figure 54. Europe HIV Drugs Sales Share by Country (2018-2029)
Figure 55. Germany HIV Drugs Revenue (2018-2029) & (US$ Million)
Figure 56. France HIV Drugs Revenue (2018-2029) & (US$ Million)
Figure 57. U.K. HIV Drugs Revenue (2018-2029) & (US$ Million)
Figure 58. Italy HIV Drugs Revenue (2018-2029) & (US$ Million)
Figure 59. Russia HIV Drugs Revenue (2018-2029) & (US$ Million)
Figure 60. China HIV Drugs Sales Market Share by Type (2018-2029)
Figure 61. China HIV Drugs Revenue Market Share by Type (2018-2029)
Figure 62. China HIV Drugs Sales Market Share by Application (2018-2029)
Figure 63. China HIV Drugs Revenue Market Share by Application (2018-2029)
Figure 64. Asia HIV Drugs Sales Market Share by Type (2018-2029)
Figure 65. Asia HIV Drugs Revenue Market Share by Type (2018-2029)
Figure 66. Asia HIV Drugs Sales Market Share by Application (2018-2029)
Figure 67. Asia HIV Drugs Revenue Market Share by Application (2018-2029)
Figure 68. Asia HIV Drugs Revenue Share by Region (2018-2029)
Figure 69. Asia HIV Drugs Sales Share by Region (2018-2029)
Figure 70. Japan HIV Drugs Revenue (2018-2029) & (US$ Million)
Figure 71. South Korea HIV Drugs Revenue (2018-2029) & (US$ Million)
Figure 72. China Taiwan HIV Drugs Revenue (2018-2029) & (US$ Million)
Figure 73. Southeast Asia HIV Drugs Revenue (2018-2029) & (US$ Million)
Figure 74. India HIV Drugs Revenue (2018-2029) & (US$ Million)
Figure 75. Middle East, Africa and Latin America HIV Drugs Sales Market Share by Type (2018-2029)
Figure 76. Middle East, Africa and Latin America HIV Drugs Revenue Market Share by Type (2018-2029)
Figure 77. Middle East, Africa and Latin America HIV Drugs Sales Market Share by Application (2018-2029)
Figure 78. Middle East, Africa and Latin America HIV Drugs Revenue Market Share by Application (2018-2029)
Figure 79. Middle East, Africa and Latin America HIV Drugs Revenue Share by Country (2018-2029)
Figure 80. Middle East, Africa and Latin America HIV Drugs Sales Share by Country (2018-2029)
Figure 81. Brazil HIV Drugs Revenue (2018-2029) & (US$ Million)
Figure 82. Mexico HIV Drugs Revenue (2018-2029) & (US$ Million)
Figure 83. Turkey HIV Drugs Revenue (2018-2029) & (US$ Million)
Figure 84. Israel HIV Drugs Revenue (2018-2029) & (US$ Million)
Figure 85. GCC Countries HIV Drugs Revenue (2018-2029) & (US$ Million)
Figure 86. HIV Drugs Value Chain
Figure 87. HIV Drugs Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Abacavir Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Abacavir market: According to our latest research, the global Abacavir market looks promising in the next 5 years. As of 2022, the global Abacavir market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Abacavir market, with a systematical descriptio......

Global Abacavir Market Research Report 2023

Published: 05-Dec-2023        Price: US 2900 Onwards        Pages: 85

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Abacavir market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - GSK - Aurobindo - Novnauki - Smilax - Hycultec - Atripla Segment by Type - Tablet Abacavir - Oral Solution Abacavir S......

Global Zidovudine Market Research Report 2023, Forecast to 2028

Published: 22-Nov-2023        Price: US 2680 Onwards        Pages: 136

Zidovudine is used along with other medications to treat human immunodeficiency virus (HIV) infection. Zidovudine is given to HIV-positive pregnant women to reduce the chance of passing the infection to the baby. Zidovudine is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (m......

Global Zidovudine Professional Survey Report 2023, Forecast to 2028

Published: 22-Nov-2023        Price: US 3280 Onwards        Pages: 104

Zidovudine is used along with other medications to treat human immunodeficiency virus (HIV) infection. Zidovudine is given to HIV-positive pregnant women to reduce the chance of passing the infection to the baby. Zidovudine is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (m......

Global Abacavir Sulfate Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 29-Aug-2023        Price: US 3380 Onwards        Pages: 127

Market Overview of Global Abacavir Sulfate market: According to our latest research, the global Abacavir Sulfate market looks promising in the next 5 years. As of 2022, the global Abacavir Sulfate market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Abacavir Sulfate market......

Global Zidovudine Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 75

Zidovudine (ZDV), also known as azidothymidine (AZT), is an antiretroviral medication used to prevent and treat HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used to prevent mother-to-child spread during birth or after a needlestick injury or other potential exposure. It is sold both by itself and together as lamivudine/zidovudine and abacavir/lamivudine/zidovudine. It can be used by mouth or by slow injection into a vein. The global Zidovudin......

Global HIV Drugs Market Insights, Forecast to 2029

Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 93

HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population. The global HIV Drugs market is projected to grow from US$ 23910 million in 2023 to US$ 26950 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.0% during the forecast period.......

HIV Treatment Drugs Industry Forecasts - China Focus

Published: 24-Jul-2023        Price: US 1800 Onwards        Pages: 91

This study focuses on China's HIV Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......

HIV Treatment Drugs Markets in China

Published: 24-Jul-2023        Price: US 4000 Onwards        Pages: 225

China's demand for HIV Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, ind......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs